Clinical feasibility study for the use of implanted gold seeds in the prostate as reliable positioning markers during megavoltage irradiation

Radiotherapy and Oncology

Volumn 67, Issue 3, 2003, Pages 295-302

  Dehnad, Homan ^a   Nederveen, Aart J ^a   Van Der Heide, Uulke A ^a   Van Moorselaar, R Jeroen A ^a   Hofman, Pieter ^a   Lagendijk, Jan J W ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Feasibility study; Gold markers; Migration; Position verification; Prostate deformation

Indexed keywords

GOLD;

ACCURACY; ACUTE TOXICITY; ADULT; AGED; ANTERIOR POSTERIOR AXIS; ARTICLE; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; DIARRHEA; DYSURIA; FEASIBILITY STUDY; GASTROINTESTINAL TOXICITY; HUMAN; IMPLANT; IMPLANTATION; MALE; MEGAVOLTAGE RADIATION; POSITION; PRIORITY JOURNAL; PROSTATE; PROSTATE CARCINOMA; RADIATION SICKNESS; RATING SCALE; RELIABILITY; ROTATION; SAFETY; SCORING SYSTEM; URINARY FREQUENCY; UROGENITAL TRACT DISEASE;

EID: 0037966410     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(03)00078-1     Document Type: Article

References (24)

1. Common Toxicity Criteria Version 2.0. National Cancer Institute 1998.
2. Aron M., Rajeev T.P., Gupta N.P. Antibiotic prophylaxis for transrectal needle biopsy of the prostate: a randomized controlled study. BJU Int. 85:2000;682-685.
3. Balter J.M., Lam K.L., Sandler H.M., Littles J.F., Bree R.L., Ten Haken R.K. Automated localization of the prostate at the time of treatment using implanted radiopaque markers: technical feasibility. Int J Radiat Oncol Biol Phys. 33:1995;1281-1286.
4. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-78 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys. 41:1998;83-92.
5. Burman C., Chui C., Kutcher G., et al. Planning, delivery, and quality assurance of intensity modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys. 39:1997;863-873.
6. Crook J.M., Raymond Y., Salhani D., Yang H., Esche B. Prostate motion during standard radiotherapy as assessed by fiducial markers. Radiother Oncol. 37:1995;35-42.
7. Gall K.P., Verhey L.J. Computer-assisted positioning of radiotherapy patients using implanted radiopaque fiducials. Med Phys. 20:1993;1153-1159.
8. Langen K.M., Jones D.T.L. Organ motion and its management. Int J Radiat Oncol Biol Phys. 50:2001;265-278.
9. Litzenberg D., Dawson L., Sandler H., et al. Daily prostate targeting using implanted radiopaque markers. Int J Radiat Oncol Biol Phys. 52:2002;699-703.
10. Nederveen A.J., Lagendijk J.J.W., Hofman P. Feasibility of automatic marker detection with an a-Si flat-panel imager. Phys Med Biol. 46:2001;1219-1230.
11. Nederveen A.J., Van der Heide U.A., Dehnad H., Van Moorselaar R.J.A., Hofman P., Lagendijk J.J.W. Measurements and clinical consequences of prostate motion during a radiotherapy fraction. Int J Radiat Oncol Biol Phys. 53:2002;206-214.
12. Perez C.A., Brady L.W. Principles and practice of radiation oncolog. 3rd edition Lippincott-Raven. 1998;Lippincott-Raven.
13. Rasch C., Barillot I., Remeijer P., Touw A., Van Herk M., Lebesque J.V. Definition of the prostate in CT and MRI: a multi-observer study. Int J Radiat Oncol Biol Phys. 43:(57):1999;66.
14. Remeijer P., Rasch C., Lebesque J.V., Van Herk M. Margins for translational and rotational uncertainties: a probability-based approach. Int J Radiat Oncol Biol Phys. 53:2002;464-474.
15. Sandler H.M., Bree R.L., McLaughlin P.W., Grossman H.B., Lichter A.S. Localization of the prostatic apex for radiation therapy using implanted markers. Int J Radiat Oncol Biol Phys. 27:1993;915-919.
16. Sandler H.M., McLaughlin P.W., Ten Haken R.K., Addison H., Forman J., Lichter A. Three dimensional conformal radiotherapy for the treatment of prostate cancer: low risk of chronic rectal morbidity observed in a large series of patients. Int J Radiat Oncol Biol Phys. 33:1995;797-801.
17. Shirato H., Shimizu S., Kitamura K., et al. Four-dimensional treatment planning and fluoroscopic real-time tumor tracking radiotherapy for moving tumor. Int J Radiat Oncol Biol Phys. 48:2000;435-442.
18. Stroom J.C., de Boer J.C.J., Huizenga H., Visser A.G. Inclusion of geometrical uncertainties in radiotherapy treatment planning by means of coverage probability. Int J Radiat Oncol Biol Phys. 43:1999;905-919.
19. Stroom J.C., Koper P.C.M., Korevaar G.A., et al. Internal organ motion in prostate cancer patients treated in prone and supine treatment position. Radiother Oncol. 51:1999;237-248.
20. Van Herk M., Bruce A., Kroes G., Shouman T., Touw A., Lebesque J.V. Quantification of organ motion during conformal radiotherapy of the prostate by three dimensional image registration. Int J Radiat Oncol Biol Phys. 33:1995;1311-1320.
21. Van Herk M., Remeijer P., Rasch C., Lebesque J.V. The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. Int J Radiat Oncol Biol Phys. 47:2000;1121-1135.
22. Vigneault E., Pouliot J., Laverdière J., Roy J., Dorion M. Electronic portal imaging device detection of radioopaque markers for the evaluation of prostate position during megavoltage irradiation: a clinical study. Int J Radiat Oncol Biol Phys. 37:1997;205-212.
23. Wu J., Haycocks T., Alasti H., et al. Positioning error and prostate motion during conformal prostate radiotherapy using on-line isocentre set-up verification and implanted prostate markers. Radiother Oncol. 61:2001;127-133.
24. Zelefsky M.J., Leibel S.A., Gaudin P.B., et al. Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer. Int J Radiat Oncol Biol Phys. 41:1998;491-500.